Table 1:
Characteristics of the study groups:
| Characteristic | Congenital urological anomaly (n=35) | Other diagnoses (n=57) | p-value | Statistical test used |
|---|---|---|---|---|
| Age (years) Mean (SD) |
14.1 (1.86) | 14.0 (2.08) | 0.85 | t-test |
| Child Sex (%male) | 27 (77.1%) | 33 (57.9%) | 0.06 | Chi squared test |
| Parent Sex (% female) |
29 (82.9%) | 47 (82.46%) | 0.96 | Chi-squared test |
| Biological parent (%) | 32 (91.4%) | 54 (94.7%) | 0.67 | Fisher’s exact test |
| Parent race (% white) | 31 (88.6%) | 32 (57.1%) | 0.002 | Fisher’s exact test |
| Hematocrit Mean (SD) |
34.0 (4.29) | 34.6 (5.42) | 0.62 | t-test |
| Transplant (%) | 22 (62.9%) | 31 (54.4%) | 0.43 | Chi-squared test |
| CRF (%) | 13 (37.1%) | 26 (45.6%) | 0.43 | Chi-squared test |
| Albumin Mean (SD) |
4.1 (0.38) | 4.1 (0.50) | 0.70 | t-test |
| CKD Stage (%) | ||||
| Stage I | 3 (10%) | 12 (21.4%) | 0.06 | Fisher’s exact test |
| Stage II | 10 (33.3%) | 19 (33.9%) | ||
| Stage III | 14 (46.7%) | 14 (25%) | ||
| Stage IV | 1 (3.33%) | 10 (17.9%) | ||
| Stage V | 2 (6.7%) | 1 (1.8%) | ||